6 January 2012 - Japan's Takeda Pharmaceutical Company Limited (TYO:4502) said today it had established a three-year research partnership with Osaka University for vaccines containing nano-particles.

The joint research will focus on the development of a platform for the practical appli...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up